Schedule Update - effective 1 May 2008 (text extract)

This is the text extract for Schedule Update - effective 1 May 2008 , browse documents here.

Pharmaceutical Management Agency

Update

New Zealand Pharmaceutical Schedule

Effective 1 May 2008

Contents

Summary of PHARMAC decisions effective 1 May 2008 ................................ 3 New PHARMAC website designed to meet users’ needs................................ 4 Methylphenidate Special Authority Form Correction ..................................... 5 Changes to the Format of the Pharmaceutical Schedule ............................... 5 Tender News .................................................................................................. 6 Looking Forward ........................................................................................... 6 Sole Subsidised Supply products cumulative to May 2008 ............................ 7 New Listings ................................................................................................ 16 Changes to Restrictions ............................................................................... 17 Changes to Subsidy and Manufacturer’s Price............................................. 18 Changes to PSO........................................................................................... 19 Changes to Sole Subsidised Supply ............................................................. 19 Delisted Items ............................................................................................. 20 Items to be Delisted .................................................................................... 21 Section H changes ....................................................................................... 22 Index ........................................................................................................... 24

Summary of PharmaC decisions

effeCtive 1 may 2008 New listing (page 16) • Insulin pen needles (ABM) 29 g x 12.7mm, 31 g x 6 mm and 31 g x 8 mm – New listing – Maximum of 100 dev per prescription • Insulin syringes disposable with attached needle (ABM) syringe 0.3 ml with 29 g x 12.7 mm needle, syringe 0.3 ml with 31 g x 8 mm needle, syringe 0.5 ml with 29 g x 12.7 mm, syringe 0.5 ml with 31 g x 8 mm needle, syringe 1 ml with 29 g x 12.7 mm needle, syringe 1 ml with 31 g x 8 mm needle - New listing – Maximum of 100 dev per prescription • Condoms (Gold Knight) 53 mm (chocolate and strawberry) – New listing • Ritonavir (Norvir) cap 100 mg, 84 capsule pack size – New listing – Special Authority for subsidy • Venlafaxine (Efexor XR) cap 37.5 mg – New listing – Special Authority for subsidy Changes to restriction (page 17) • Pyrazinamide (AFT-Pyrazinamide) tab 500 mg – Removal of S29 Decreased subsidy (page 18) • Omeprazole (Dr Reddy’s Omeprazole) cap 10 mg, 20 mg and 40 mg • Dextrose (Biomed) inj 50%, 10 ml • Glyceryl trinitrate (Nitroderm TTS) TDDS 5 mg and TDDS 10 mg • Oestradiol (Estrofem) tab 2 mg • Leflunomide (AFT-Leflunomide) tab 10mg and 20 mg

4 Pharmaceutical Schedule - Update News

New PHARMAC website designed to meet users’ needs

We have redesigned our website to make it easier to find information about how PHARMAC works and the funding decisions that are made. It is easier to find resources, Special Authority forms and Schedule information. The design was developed in conjunction with the people who use the site: prescribers, pharmacists, patients and other users. The new site, released 14 April 2008, has a completely revised structure from the previous website, although the website address remains the same: www. pharmac.govt.nz. The PHARMAC site is widely used with one of its web pages being accessed about once every three minutes. It is most frequently used by health professionals to access information on medicine subsidies and to download Special Authority forms. The new site provides a full version of the Pharmaceutical Schedule online and now lists pharmacodes for all subsidised products. Other commonly used features of the website are links to PHARMAC’s consultation documents and media releases. A new feature of the website is an interactive flow chart illustrating PHARMAC’s decision making process. This is designed to help people better understand and navigate through the steps in the medicines funding process. Features of the new site include: • Dedicated sections for consumers & patients, health professionals, the pharmaceutical industry and District Health Boards

• Improved structure to aid navigation • An interactive flow chart to help people navigate through the decision making process • Clearer explanation of PTAC’s role (PHARMAC’s clinical advisory committee) • An improved search engine to help people find documents • Links to more information on medicine interactions and side effects • Links to sites with information on PHARMAC activities promoting the responsible use of medicines, such as One Heart Many Lives and Wise Use of Antibiotics.

Pharmaceutical Schedule - Update News

Methylphenidate Special Authority Form Correction

An incorrect version of the methylphenidate Special Authority (SA0908) was inadvertently loaded onto our website and the electronic Special Authority system from 1 April to 14 April. This has now been corrected, although MedTech users may be unable to make electronic Special Authority applications for methylphenidate until 1 May 2008. Of note, the incorrect version contained a requirement under the ADHD criteria for patients to have seen a specialist in person within the past 18 months, whereas the correct version requires that a specialist must have recommended treatment within the past 2 years.

Changes to the Format of the Pharmaceutical Schedule

We have made some improvements to the April 2008 edition of the Pharmaceutical Schedule. The maximum quantity available on a Practitioners Supply Order (PSO) is now listed with the main listing in Section B of the Pharmaceutical Schedule. This eliminates the need to refer to the PSO list in Section E for ordering items on a PSO. The PSO list in Section E has also been amended so that the pharmaceuticals available on a PSO are listed in alphabetical order rather than by therapeutic group. Level 2 therapeutic group headings are now listed in the index. These are the headings that appear in white print on a black background and include headings like ‘Antiparkinson Agents’ and ‘Sedatives and Hypnotics’.

tender News

Sole Subsidised Supply changes – effective 1 June 2008

Chemical Name Clarithromycin Pantoprazole Pantoprazole Presentation; Pack size Tab 250 mg; 14 tab Tab 20 mg; 28 tab Tab 40 mg; 28 tab Sole Subsidised Supply brand (and supplier) Klamycin (Pacific) Dr Reddy’s Pantoprazole (Affordable Healthcare Ltd) Dr Reddy’s Pantoprazole (Affordable Healthcare Ltd)

Looking forward

This section is designed to alert both pharmacists and prescribers to possible future changes. It may assist pharmacists to manage stock levels and keep prescribers up-to-date with proposals to change the Pharmaceutical Schedule. Possible decisions for implementation 1 June 2008 • Condoms (Gold Knight) 49 mm, 55 mm and 53 mm extra strength - available on a PSO – new listing • Condoms 52 mm (Marquis Supalite), 52 mm extra strength (Marquis Protecta), 54 mm shaped (Lifestyles Flared), and 56 mm shaped (Durex Confidence) – subsidy decrease • Hydroxocobalamin (ABM) inj 1 mg per ml, 1 ml– new listing • Salbutamol (Respigen) aerosol inhaler 100 mcg per dose, CFC-free – new listing • Salbutamol (Salamol, Ventolin) aerosol inhaler 100 mcg per dose, CFC-free – decreased subsidy • Lamotrigine (Logem) tab dispersible 25 mg, 50 mg and 100 mg – new listing • Rizatriptan benzoate wafer 10 mg (Maxalt Melt) – new listing • Losartan – new Special Authority criteria • Losartan with hydrochlorothiazide – new Special Authority criteria • Changes to close control rules

Sole Subsidised Supply Products – cumulative to May 2008

Generic Name

Acetazolamide Acipimox Acitretin Allopurinol Alprazolam

Presentation

Tab 250 mg Cap 250 mg Cap 10 mg & 25 mg Tab 100 mg & 300 mg Tab 250 µg Tab 500 µg Tab 1 mg Tab 10 mg, 25 mg & 50 mg Tab 5 mg & 10 mg Inj 10 mg per ml, 1 ml Cap 250 mg & 500 mg Grans for oral liq 125 mg per 5 ml Grans for oral liq 250 mg per 5 ml Inj 250 mg, 500 mg & 1 g Device Cream Tab 100 mg Tab 100 mg Tab 50 mg & 100 mg Inj 600 µg, 1 ml Inj 1200 µg, 1 ml Eye drops 1% Tab 500 mg Metered aqueous nasal spray 50 µg Metered aqueous nasal spray 100 µg Scalp app 0.1% Crm 0.1% Oint 0.1% Tab 200 mg Tab 5 mg Eye drops 0.2% Tab 2.5 mg & 10 mg Inj 0.5%, 4 ml Inj 0.5%, 8% glucose, 4 ml Lotion BP Crm, aqueous, BP Cap 0.25 µg & 0.5 µg Tab dispersible 2.5 g Tab 1.25 g Tab 1.5 g

Brand Name Expiry Date*

Diamox Olbetam Neotigason Progout Arrow-Alprazolam Arrow-Alprazolam Arrow-Alprazolam Amitrip Calvasc Mayne Apo-Amoxi Ranbaxy Amoxicillin Ranbaxy Amoxicillin Ibiamox Ortho Multichem Apo-Ascorbic Acid Ethics Aspirin EC Loten AstraZeneca AstraZeneca Atropt Arrow-Azithromycin Alanase Alanase Beta Scalp Beta Cream Beta Ointment Fibalip Lax-Tab AFT Alpha-Bromocriptine Marcain Isobaric Marcain Heavy ABM ABM Calcitriol-AFT Calci-Tab Effervescent Calci-Tab 500 Calci-Tab 600 2008 2008 2008 2008 2010

Amitriptyline Amlodipine Apomorphine hydrochloride Amoxycillin

2008 2008 2009 2010 2009 2008 2008 2008 2009 2010 2009 2009 2008 2009 2009 2009 2008 2008 2010 2008 2008 2010 2009 2009 2008

Applicator Aqueous cream Ascorbic acid Aspirin Atenolol Atropine sulphate

Azithromycin Beclomethasone dipropionate Betamethasone valerate

Bezafibrate Bisacodyl Brimonidine tartrate Bromocriptine mesylate Bupivicaine hydrochloride Calamine Calcitriol Calcium carbonate

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 7

Sole Subsidised Supply Products – cumulative to May 2008

Generic Name

Calcium folinate Captopril Cefaclor monohydrate Cefazolin sodium Ceftriaxone sodium Cetirizine hydrochloride Cetomacrogol Chloramphenicol Chlorhexidine gluconate

Presentation

Inj 50 mg Tab 12.5 mg, 25 mg & 50 mg Cap 250 mg Grans for oral liq 125 mg per 5 ml Inj 500 mg & 1 g Inj 500 mg & 1 g Oral liq 1 mg per ml Tab 10 mg Crm BP Eye drops 0.5% Eye oint 1% Handrub 1% with ethanol 70% Mouthwash 0.2% Soln 4% Tab 25 mg Tab 250 mg, 500 mg & 750 mg Grans for oral liq 125 mg per 5 ml Cap hydrochloride 150 mg Inj phosphate 150 mg per ml, 4 ml Crm 0.05% Scalp app 0.05% Oint 0.05% Tab 500 µg & 2 mg TDDS 2.5 mg, 100 µg per day TDDS 5 mg, 200 µg per day TDDS 7.5 mg, 300 µg per day Tab 25 µg Tab 150 µg Inj 150 µg per ml, 1 ml Vaginal crm 1% with applicator(s) Crm 1% Tab 15 mg, 30 mg & 60 mg Tab 500 µg Sach 5 g Inj 150 mg Powder for soln for oral use Oral liq sugar-free trimethoprim 40 mg and sulphamethoxazole 200 mg per 5 ml Tab trimethoprim 80 mg and sulphamethoxazole 400 mg

Brand Name Expiry Date*

Calcium Folinate Ebewe Apo-Captopril Ranbaxy Cefaclor Ranbaxy Cefaclor m-Cefazolin AFT Allerid C Razene PSM Chlorsig Chlorsig Orion Orion Orion Hygroton Cipflox Klacid Dalacin C Dermol Dermol Dermol Paxam Catapres-TTS-1 Catapres-TTS-2 Catapres-TTS-3 Dixarit Catapres Catapres Clomazol Clomazol PSM Colgout Colestid Colistin-Link Enerlyte Trisul 2008 2010 2010 2008 2008 2008 2010 2009 2009 2008 2009 2008 2010 2008 2009 2008 2008 2008

Chlorthalidone Ciprofloxacin Clarithromycin Clindamycin Clobetasol propionate

Clonazepam Clonidine

Clonidine hydrochloride

2008

Clotrimazole Codeine phosphate Colchicine Colestipol hydrochloride Colistin sulphomethate Compound electrolytes Co-trimoxazole

2010 2008 2010 2010 2010 2010 2010 2008

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 8

Sole Subsidised Supply Products – cumulative to May 2008

Generic Name

Cyclizine hydrochloride Cyclizine lactate Cyclophosphamide Cyproterone acetate Dantrolene sodium Desferrioxamine mesylate Desmopressin Dexamethasone sodium phosphate Dexamphetamine sulphate Dextrose with electrolytes

Presentation

Tab 50 mg Inj 50 mg per ml, 1 ml Tab 50 mg Tab 50 mg Cap 25 mg & 50 mg Inj 500 mg Nasal spray 10 µg per dose Inj 4 mg per ml, 1 ml Inj 4 mg per ml, 2 ml Tab 5 mg Oral soln with electrolytes

Brand Name Expiry Date*

Nausicalm Valoid (AFT) Cycloblastin Siterone Dantrium Mayne Desmopressin-PH&T Mayne PSM Pedialyte – Plain Pedialyte – Bubblegum Pedialyte – Fruit Ortho All-flex & Ortho Coil Apo-Diclo Apo-Diclo SR Videx EC DHC Continus Diastop Pytazen SR Coloxyl Apo-Doxazosin AFT m-Enalapril Mayne Cafergot E-Mycin E-Mycin Myambutol New Zealand Medical and Scientific 2009 2008 2010 2009 2009 2010 2008 2009 2010 2010

Diaphragm Dicloflenac sodium Didanosine (DDI) Dihydrocodeine tartrate Diphenoxylate hydrochloride with atropine sulphate Dipyridamole Docusate sodium Doxazosin mesylate Emulsifying ointment BP Enalapril Ergometrine maleate Ergotamine tartrate with caffeine Erythromycin ethyl succinate Ethambutol hydrochloride Ethinyloestradiol

Range of sizes Tab EC 25 mg & 50 mg Tab long-acting 75 mg & 100 mg Cap 125 mg, 200 mg, 250 mg & 400 mg Tab long-acting 60 mg Tab 2.5 mg with atropine sulphate 25 µg Tab long-acting 150 mg Tab 50 mg & 120 mg Tab 2 mg & 4 mg Ointment Tab 5 mg, 10 mg & 20 mg Inj 500 µg per ml, 1 ml Tab 1 mg with caffeine 100 mg Grans for oral liq 200 mg per 5 ml Grans for oral liq 400 mg per 5 ml Tab 400 mg Tab 10 µg

2008 2009 2009 2008 2008 2008 2008 2010 2008 2009 2009 2009 2008 2008 2009

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 9

Sole Subsidised Supply Products – cumulative to May 2008

Generic Name

Ethinyloestradiol with norethisterone

Presentation

Tab 35 µg with norethisterone 500 µg Tab 35 µg with norethisterone 1 mg Tab 35 µg with norethisterone 1 mg and 7 inert tab Tab 35 µg with norethisterone 500 µg and 7 inert tab Cap 50 mg & 100 mg Oral liq 150 mg per 5 ml Cap 250 mg & 500 mg Grans for oral liq 125 mg per 5 ml Grans for oral liq 250 mg per 5 ml Cap 50 mg, 150 mg & 200 mg Oint 950 µg, with fluocortolone pivalate 920 µg, and cinchocaine hydrochloride 5 mg per g Suppos 630 µg, with fluocortolone pivalate 610 µg, and cinchocaine hydrochloride 1 mg Eye drops 0.1% Cap 20 mg Tab disp 20 mg, scored Inj 12.5 mg per 0.5 ml, 0.5 ml Inj 25 mg per ml, 1 ml Inj 100 mg per ml, 1 ml Tab 0.8 mg & 5 mg Crm 2% & Oint 2% Inj 40 mg per ml, 2 ml Tab 80 mg Tab 5 mg Oral liq 2 mg per ml Tab 500 µg, 1.5 mg & 5 mg Inj 5 mg per ml, 1 ml Inj 50 mg per ml, 1 ml Inj 100 mg per ml, 1 ml Inj 10 iu per ml, 5 ml Tab 5 mg & 20 mg Powder 25 g Rectal foam 10%, CFC-Free Scalp lotn 0.1% Lotn 1% with wool fat hydrous 3% and mineral oil

Brand Name Expiry Date*

Brevinor 21 Brevinor 1/21 Brevinor 1/28 Norimin Vepesid Ferodan Staphlex AFT AFT Pacific Ultraproct Ultraproct 2008 2009 2010 2009 2010

Etoposide Ferrous sulphate Flucloxacillin sodium

Fluconazole Fluocortolone caproate with fluocortolone pivalate and cinchocaine

2008 2010

Fluorometholone Fluoxetine hydrochloride Fluphenazine decanoate

Flucon Fluox Fluox Modecate Modecate Modecate Apo-Folic Acid Foban Pfizer Apo-Gliclazide Minidiab Serenace Serenace Serenace Haldol Haldol Concentrate AstraZeneca Douglas m-Hydrocortisone Colifoam Locoid DP Lotn HC

2009 2010 2008

Folic Acid Fusidic acid Gentamicin sulphate Gliclazide Glipizide Haloperidol

2009 2010 2009 2008 2008 2010 2009 2008 2009 2009 2008 2009 2010 2008

Haloperidol decanoate Heparinised saline Hydrocortisone Hydrocortisone acetate Hydrcortisone butyrate Hydrocortisone with wool fat and mineral oil

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 10

Sole Subsidised Supply Products – cumulative to May 2008

Generic Name

Hyoscine N-butylbromide Hypromellose Ibuprofen Imipramine hydrochloride Indapamide Indomethacin Ipratropium bromide

Presentation

Tab 10 mg Inj 20 mg Eye drops 0.3% Eye drops 0.5% Oral liq 100 mg per 5 ml, 200 ml Tab 200 mg Tab 10 mg & 25 mg Tab 2.5 mg Cap 25 mg & 50 mg Aqueous nasal spray, 0.03% Nebuliser soln, 250 µg per ml, 1 ml Nebuliser soln, 250 µg per ml, 2 ml Aerosol inhaler, 20 µg per dose CFC-free Tab long-acting 60 mg Cap 10 mg Cap 20 mg Cap 100 mg Shampoo 2% Oral liq 10 g per 15 ml Eye drops 0.25% & 0.5% Cap 50 mg with benserazide 12.5 mg Tab dispersible 50 mg with benserazide 12.5 mg Cap 100 mg with benserazide 25 mg Cap long-acting 100 mg with benserazide 25 mg Cap 200 mg with benserazide 50 mg Inj 0.5%, 5 ml Inj 1%, 5 ml Inj 1%, 20 ml Crm 2.5% with prilocaine 2.5%; 30 g OP Crm 2.5% with prilocaine 2.5%; 5 g Tab 5 mg, 10 mg & 20 mg Tab 2 mg Tab 10 mg Oral liq 1 mg per ml

Brand Name Expiry Date*

Gastrosoothe Buscopan Poly-Tears Methopt Fenpaed I-Profen Tofranil Napamide Rheumacin Apo-Ipravent Ipratripium Steri-Neb Ipratripium Steri-Neb Atrovent Duride Isotane 10 Isotane 20 Sporanox Ketopine Duphalac Betagan Madopar 62.5 Madopar Dispersible Madopar 125 Madopar HBS Madopar 250 Xylocaine Xylocaine Xylocaine EMLA EMLA Arrow-Lisinopril Nodia Loraclear Hayfever Relief Lorapaed Ativan Mayne Derbac M 2009 2010 2010 2010 2008 2008 2010 2008 2009 2009 2008 2010 2008 2009 2009 2010 2008 2010 2010 2009

Isosorbide mononitrate Isotretinoin Itraconazole Ketoconazole Lactulose Levobunolol Levodopa with benserazide

Lignocaine hydrochloride

Lignocaine with prilocaine

2010

Lisinopril Loperamide hydrochloride Loratadine

Lorazepam Magnesium sulphate Malathion

Tab 1 mg & 2.5 mg Inj 49.3% Liq 0.5%

2009 2009 2010

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 11

Sole Subsidised Supply Products – cumulative to May 2008

Generic Name

Maldison Maprotiline hydrochloride Medroxyprogesterone acetate Mesalazine Metformin hydrochloride Methadone hydrochloride Methotrexate

Presentation

Shampoo 1% Tab 25 mg & 75 mg Tab 2.5 mg, 5 mg, 10 mg, 100 mg & 200 mg Enema 1 g per 100 ml Tab 500 mg & 850 mg Tab 5 mg Powder 1 g Tab 2.5 mg & 10 mg Inj 100 mg per ml, 5 ml Inj 100 mg per ml, 10 ml Inj 100 mg per ml, 50 ml Tab 125 mg, 250 mg & 500 mg Tab long-acting 20 mg Tab 5 mg & 20 mg Tab 10 mg Tab 4 mg & 100 mg Crm 0.1% and oint 0.1% Inj 40 mg per ml, 1 ml Inj 40 mg per ml with lignocaine 1 ml Inj 40 mg per ml, 1 ml Inj 62.5 mg per ml, 1 ml Inj 500 mg & 1 g Inj 5 mg per ml, 2 ml Tab long-acting 200 mg Cap 250 mg Cap 50 mg & 200 mg Crm 2% Tab 2.5 mg & 5 mg Tab 200 µg Tab 150 mg & 300 mg Oral liq 1 mg per ml Oral liq 2 mg per ml Oral liq 5 mg per ml Oral liq 10 mg per ml

Brand Name Expiry Date*

A-Lices Ludiomil Provera Pentasa Arrow-Metformin Methatabs AFT Methoblastin Methotrexate Ebewe Methotrexate Ebewe Methotrexate Ebewe Prodopa Rubifen SR Rubifen Rubifen Medrol Advantan Depo-Medrol Depo-Medrol with Lidocaine Solu-Medrol Solu-Medrol Solu-Medrol Pfizer Slow-Lopressor Metopirone Mexitil Multichem Gutron Cytotec Apo-Moclobemide RA-Morph RA-Morph RA-Morph RA-Morph 2010 2009 2010 2009 2009 2010 2009 2009 2008

Methyldopa Methylphenidate hydrochloride

2008 2009

Methylprednisolone Methylprednisolone aceponate Methylprednisolone acetate Methylprednisolone acetate with lignocaine Methylprednisolone sodium succinate Metoclopramide hydrochloride Metoprolol tartrate Metyrapone Mexiletine hydrochloride Miconazole nitrate Midodrine Misoprostol Moclobemide Morphine hydrochloride

2009 2009 2008 2008 2009

2008 2009 2009 2008 2008 2009 2009 2009 2009

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 12

Sole Subsidised Supply Products – cumulative to May 2008

Generic Name

Morphine sulphate

Presentation

Inj 5 mg per ml, 1 ml Inj 15 mg per ml, 1 ml Cap long-acting 10 mg, 30 mg, 60 mg, 100 mg & 200 mg Tab immediate release 10 mg & 20 mg Inj 80 mg per ml, 1.5 ml & 5 ml Tab 40 mg & 80 mg Tab 50 mg Eye drops 0.1% Tab 250 mg Tab 500 mg Tab long-acting 750 mg Tab long-acting 1000 mg Tab 275 mg Inj 2.5 mg per ml, 1 ml Oral suspension 10 mg per ml Tab 50 mg & 500 mg Tab long-acting 20 mg Jelly 2% Tab 350 µg Tab 5 mg Tab 400 mg Tab 10 mg & 25 mg Cap 500,000 u Tab 500,000 u Vaginal crm 100,000 u per 5 g with applicators Oral liq 100,000 u per ml Tab 4 mg & 8 mg Tab disp 4 mg & 8 mg Tab 5 mg Oral liq 5 mg per 5 ml Inj 10 mg per ml, 1 ml and 2 ml Oral liq 5 mg per 5 ml Inj 5 iu per ml, 1 ml Inj 10 iu per ml, 1 ml Inj 5 iu with ergometrine maleate 500 µg per ml, 1 ml Inj 3 mg per ml, 5 ml Inj 3 mg per ml, 10 ml Inj 6 mg per ml, 10 ml

Brand Name Expiry Date*

Mayne Mayne m-Eslon Sevredol Mayne Apo-Nadolol ReVia Naphcon Forte Noflam 250 Noflam 500 Naprosyn SR 750 Naprosyn SR 1000 Sonaflam AstraZeneca Viramune Suspension Apo-Nicotinic Acid Nyefax Retard Gynol II Noriday 28 Primolut-N Arrow-Norfloxacin Norpress Nilstat Nilstat Nilstat Nilstat Zofran Zofran Zydis Apo-Oxybutynin Apo-Oxybutynin OxyNorm OxyNorm Syntocinon Syntocinon Syntometrine Pamisol Pamisol Pamisol 2009 2010 2010 2008 2009 2008 2010 2010 2009 2009 2009 2008 2009 2008 2008 2008 2010 2009 2008 2010 2010 2010 2009 2009

Morphine tartrate Nadolol Naltrexone hydrochloride Naphazoline hydrochloride Naproxen

Naproxen sodium Neostigmine Nevirapine Nicotinic acid Nifedipine Nonoxynol-9 Norethisterone Norfloxacin Nortriptyline Nystatin

Ondansetron Oxybutynin Oxycodone hydrochloride Oxytocin

Pamidronate disodium

2008

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 13

Sole Subsidised Supply Products – cumulative to May 2008

Generic Name

Paracetamol

Presentation

Tab 500 mg Suppos 125 mg & 250 mg Oral liq 120 mg per 5 ml Oral liq 250 mg per 5 ml Tab 500 mg with 8 mg codeine Eye oint with soft white paraffin Tab 20 mg Tab 0.25 mg & 1 mg Tab 100 mg Grans for oral liq 125 mg per 5 ml Grans for oral liq 250 mg per 5 ml Cap potassium salt 250 mg Cap potassium salt 500 mg Eye drops 0.12% Eye drops 0.5%, 1%, 2%, 4% & 6% Oral drops 10% Tab long-acting 600 mg Inj 75 mg per ml, 10 ml Inj 150 mg per ml, 10 ml Tab 1 mg, 2.5 mg, 5 mg & 20 mg Cassette Inj 1.5 mega u Tab 10 mg & 25 mg Tab 50 mg Tab 5 mg, 10 mg & 20 mg Tab 10 mg with hydrochlorothiazide 12.5 mg Tab 20 mg with hydrochlorothiazide 12.5 mg Tab 200 mg Tab 300 mg Oral liq 150 mg per 10 ml Tab 150 mg & 300 mg Cap 150 mg Tab 150 mg & 300 mg Nebuliser soln 1 mg per ml, 2.5 ml Nebuliser soln 2 mg per ml, 2.5 ml Oral liq 2 mg per 5 ml Nebuliser soln, 2.5 mg with ipratropium bromide 0.5 mg

Brand Name Expiry Date*

Panadol Panadol Junior Parapaed Six Plus Parapaed Codalgin Laci-Lube Loxamine Permax Pexsig AFT AFT Cilicaine VK Cilicaine VK Prefrin Pilopt Coloxyl Span-K AstraZeneca AstraZeneca Apo-Prednisone MDS Quick Card Cilicaine Allersoothe Apo-Pyridoxine Accupril Accuretic 10 Accuretic 20 Q 200 Q 300 Peptisoothe Arrow Ranitidine Mycobutin Arrow-Roxithromycin Asthalin Asthalin Salapin Duolin 2009 2010 2008 2010 2009 2009 2010 2009 2008

Paracetamol with codeine Paraffin liquid with soft white paraffin Paroxetine hydrochloride Pergolide Perhexiline maleate Phenoxymethylpenicillin (Penicillin V)

2008 2010 2010 2008 2009 2010

Phenylephrine hydrochloride Pilocarpine Poloxamer Potassium chloride

2010 2008 2008 2009 2008 2008 2009 2008 2008 2009 2008 2008

Prednisone Pregnancy tests - HCG urine Procaine penicillin Promethazine hydrochloride Pyridoxine hydrochloride Quinapril Quinapril with hydrochlorothiazide

Quinine sulphate Ranitidine hydrochloride Rifabutin Roxithromycin Salbutamol

Salbutamol with ipratropium bromide

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 14

Sole Subsidised Supply Products – cumulative to May 2008

Generic Name

Selegiline hydrochloride Sodium chloride Sodium citro-tartrate Sodium cromoglycate Sulphasalazine Syrup (pharmaceutical grade) Tar with triethanolamine lauryl sulphate and fluorescein Temazepam Terbinafine Timolol maleate Thiamine hydrochloride Triamcinolone acetonide Triamcinolone acetonide with gramicidin, neomycin and nystatin

Presentation

Tab 5 mg Inj 0.9%, 5 ml & 10 ml Grans eff 4 g sachets Nasal spray 4% Tab 500 mg Tab EC 500 mg Liq Soln 2.3% with triethanolamine lauryl sulphate and fluorescein sodium Tab 10 mg Tab 250 mg Tab 10 mg Tab 50 mg Crm & Oint 0.02% Dental Paste USP 0.1% Ear drops 1 mg with nystatin 100,000 u, neomycin sulphate 2.5 mg and gramicidin 250 mcg per g Oint 1 mg with nystatin 100,000 u, neomycin sulphate 2.5 mg and gramicidin 250 µg per g Tab 125 µg Tab 250 µg Tab 300 mg Cap 25 mg & 50 mg Crm 10% Cap 300 mg Inj 50 mg per ml, 10 ml Tab long-acting 120 mg Inj 1 mg per ml, 1 ml Inj 1 mg per ml, 2 ml Tab (BPC cap strength) Tab, strong, BPC Purified for injection 20 ml Oint BP Cap 220 mg Tab 7.5 mg

Brand Name Expiry Date*

Apo-Selegiline AstraZeneca Ural Rex Salazopyrin Salazopyrin EN Midwest Pinetarsol Normison Apo-Terbinafine Apo-Timol Apo-Thiamine Aristocort Oracort Kenacomb Kenacomb 2009 2009 2010 2009 2009 2010 2008 2008 2008 2009 2009 2008 2009 2008

Triazolam Trimethoprim Trimipramine maleate Urea Ursodeoxycholic acid Vancomycin hydrochloride Verapamil hydrochloride Vincristine sulphate Vitamins Vitamin B complex Water Zinc and castor oil Zinc sulphate Zopiclone May changes are in bold type

Hypam Hypam TMP Tripress Nutraplus Actigall Pacific Verpamil SR Mayne Mayne Healtheries Apo-B-Complex Multichem Multichem Zincaps Apo-Zopiclone

2008 2008 2008 2008 2008 2008 2008 2009 2009 2009 2009 2008 2008 2008

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 15

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

New Listings

Effective 1 May 2008

31 INSULIN PEN NEEDLES – Maximum of 100 dev per prescription ❋ 29 g x 12.7 mm ...................................................................... 11.75 ❋ 31 g x 6 mm ........................................................................... 11.75 ❋ 31 g x 8 mm ........................................................................... 11.75 100 100 100 ✔ ABM ✔ ABM ✔ ABM

INSULIN SYRINGES DISPOSABLE WITH ATTACHED NEEDLE – Maximum of 100 dev per prescription ❋ Syringe 0.3 ml with 29 g × 12.7 mm needle ........................... 14.45 100 ✔ ABM ❋ Syringe 0.3 ml with 31 g × 8 mm needle ................................ 14.45 100 ✔ ABM ❋ Syringe 0.5 ml with 29 g × 12.7 mm needle ........................... 14.45 100 ✔ ABM ❋ Syringe 0.5 ml with 31 g × 8 mm needle ................................ 14.45 100 ✔ ABM ❋ Syringe 1 ml with 29 g × 12.7 mm needle .............................. 14.45 100 ✔ ABM ❋ Syringe 1 ml with 31 g × 8 mm needle ................................... 14.45 100 ✔ ABM CONDOMS ❋ 53 mm (chocolate) .................................................................... 1.11 ❋ 53 mm (strawberry) .................................................................. 1.11 12 12 ✔ Gold Knight ✔ Gold Knight ✔ Norvir ✔ Efexor XR

95 108

RITONAVIR – Special Authority see SA0779 on page 93 – Hospital pharmacy [HP1] Cap 100 mg .......................................................................... 121.27 84 VENLAFAXINE – Special Authority see SA0789 below – Retail pharmacy Cap 37.5 mg ........................................................................... 18.64 28

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions

Effective 1 May 2008

91 PYRAZINAMIDE – Retail pharmacy-Specialist No patient co-payment payable ❋ Tab 500 mg ........................................................................... 59.00 100 ✔ AFT-Pyrazinamide

S29

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Subsidy and Manufacturer’s Price

Effective 1 May 2008

27 OMEPRAZOLE ( subsidy) ❋ Cap 10 mg ................................................................................ 2.00 ❋ Cap 20 mg ................................................................................ 2.85 ❋ Cap 40 mg ................................................................................ 3.35 46 60 DEXTROSE ( subsidy) ❋ Inj 50%, 10 ml – Up to 5 inj available on a PSO ........................ 22.75 GLYCERYL TRINITRATE ( subsidy) ❋ TDDS 5 mg ............................................................................. 16.56 ❋ TDDS 10 mg ........................................................................... 19.60 POVIDONE IODINE ( price) Skin preparation, povidone iodine 10% with 70% alcohol ............ 8.13 (18.63) 1.63 (6.04) SUNSCREENS, PROPRIETARY – Sunscreens by endorsement ( price) Crm........................................................................................... 1.74 (5.84) OESTRADIOL ( subsidy) ❋ Tab 2 mg .................................................................................. 4.12 (7.00) 28 28 28 ✔ Dr Reddy’s Omeprazole ✔ Dr Reddy’s Omeprazole ✔ Dr Reddy’s Omeprazole ✔ Biomed ✔ Nitroderm TTS ✔ Nitroderm TTS

5 30 30 500 ml

Orion 100 ml Orion 50 g OP Aquasun Oil Free Faces SPF 30+ 28 OP Estrofem ✔ AFT-Leflunomide ✔ AFT-Leflunomide

LEFLUNOMIDE – Special Authority see SA0635 – Retail Pharmacy ( subsidy) Tab 10 mg .............................................................................. 55.00 30 Tab 20 mg .............................................................................. 76.00 30

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to PSO

Effective 1 May 2008

183 Condoms ...................................53 mm (chocolate) 144 Condoms ...................................53 mm (strawberry) 144

Changes to Sole Subsidised Supply

Effective 1 May 2008

For the list of new Sole Subsidised Supply products effective 1 May 2008 refer to the bold entries in the cumulative Sole Subsidised Supply table pages 7-15.

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Delisted Items

Effective 1 May 2008

47 WATER 1) On a prescription or Practitioner’s Supply Order only when on the same form as an injection listed in the Pharmaceutical Schedule requiring a solvent or diluent; or 2) On a bulk supply order; or 3) When used in the extemporaneous compounding of eye drops. Purified for inj 5 ml – Available on a PSO ................................... 9.31 50 ✔ AstraZeneca Purified for inj 10 ml – Available on a PSO ............................... 10.38 50 ✔ AstraZeneca RITONAVIR – Special Authority see SA0779 – Hospital pharmacy [HP1] Oral liq 80 mg per ml ............................................................ 277.28 Note: The 90 ml OP of Norvir will continue to be listed fully subsidised. NAPROXEN SODIUM ❋ Tab 275 mg ............................................................................. 5.00 ALPRAZOLAM – Retail pharmacy-Specialist Month Restriction Tab 250 µg .............................................................................. 4.77 (8.11) ‡ Safety cap for extemporaneously compounded oral liquid preparations. Tab 500 µg .............................................................................. 8.60 (16.26) ‡ Safety cap for extemporaneously compounded oral liquid preparations. Tab 1 mg ............................................................................... 15.70 (32.51) ‡ Safety cap for extemporaneously compounded oral liquid preparations. SULPHACETAMIDE SODIUM ❋ Eye drops 10% ......................................................................... 3.60 ACETYLCYSTEINE – Hospital pharmacy [HP1]-Specialist Inj 200 mg per ml, 10 ml ...................................................... 137.06 (242.50)

240 ml OP ✔ Norvir

99 119

100

✔ Synflex

100 Xanax 100 Xanax 100 Xanax

152 161

15 ml OP 10

✔ Acetopt

Parvolex

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Items to be Delisted

Effective 1 August 2008

52 PRAZOSIN HYDROCHLORIDE ❋ Tab 1 mg .................................................................................. 2.99 ❋ Tab 2 mg ................................................................................. 4.00 ❋ Tab 5 mg ................................................................................. 6.50 100 100 100 ✔ Hyprosin ✔ Hyprosin ✔ Hyprosin

Effective 1 November 2008

58 95 VERAPAMIL HYDROCHLORIDE ❋ Tab 80 mg ............................................................................... 6.00 100 ✔ Verpamil ✔ Norvir

RITONAVIR – Special Authority see SA0779 on page 93 – Hospital pharmacy [HP1] Cap 100 mg .......................................................................... 242.55 168 Note – the 84 pack size will continue to be listed fully subsidised

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Section H changes

Effective 1 May 2008

DEXTROSE ( price and addition of HSS) Inj 50%, 10 ml ................................Biomed GLYCERYL TRINITRATE ( price and addition of HSS) TDDS 5 mg ....................................Nitroderm TTS TDDS 10 mg ..................................Nitroderm TTS 22.75 5 1% July-08 Mayne Mini-Jet Minitran Nitrocor Nitro-Dur Minitran Nitrocor Nitro-Dur

16.56 19.60

1% 1%

July-08 July-08

INSULIN PEN NEEDLES 29 g x 12.7 mm..............................ABM 31 g x 6 mm...................................ABM 31 g x 8 mm...................................ABM

11.75 11.75 11.75

100 100 100

INSULIN SYRINGES, DISPOSABLE WITH ATTACHED NEEDLE Syringe 0.3 ml with 29 g x 12.7 mm needle ..............ABM 14.45 Syringe 0.3 ml with 31 g x 8 mm needle ...................ABM 14.45 Syringe 0.5 ml with 29 g x 12.7 mm needle ..............ABM 14.45 Syringe 0.5 ml with 31 g x 8 mm needle ...................ABM 14.45 Syringe 1 ml with 29 g x 12.7 mm needle ..............ABM 14.45 Syringe 1 ml with 31 g x 8 mm needle ...................ABM 14.45 LEFLUNOMIDE ( price) Tab 10 mg......................................AFT-Leflunomide 55.00 Tab 20 mg......................................AFT-Leflunomide 76.00 OMEPRAZOLE ( price) Cap 10 mg ....................................Dr Reddy’s Omeprazole Cap 20 mg .....................................Dr Reddy’s Omeprazole Cap 40 mg .....................................Dr Reddy’s Omeprazole 2.00 2.85 3.35

100 100 100 100 100 100 30 30 28 28 28

RITONAVIR Cap 100 mg ...................................Norvir 121.27 Cap 100 mg ...................................Norvir 242.55 Note – 168 pack size of Norvir to be delisted from 1 May 2008

84 168

Products with Hospital Supply Status (HSS) are in bold.

(B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Section H - effective 1 May 2008 (continued)

VENLAFAXINE Cap 37.5 mg ..................................Efexor XR VERAPAMIL Tab 80 mg .....................................Verpamil Verpamil tab 80 mg to be delisted from 1 May 2008 18.64 6.00 28 100

Section H Changes - effective 1 April 2008

There are no changes to Section H for 1 April 2008.

Products with Hospital Supply Status (HSS) are in bold.

(B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Index

Pharmaceuticals and brands A Acetopt .............................................................. 20 Acetylcysteine.................................................... 20 AFT-Leflunomide .......................................... 18, 22 AFT-Pyrazinamide .............................................. 17 Alprazolam ......................................................... 20 Aquasun Oil Free Faces SPF 30+ ....................... 18 C Condoms ..................................................... 16, 19 D Dextrose ...................................................... 18, 22 Dr Reddy’s Omeprazole................................ 18, 22 E Efexor XR ..................................................... 16, 23 Estrofem ............................................................ 18 G Glyceryl trinitrate .......................................... 18, 22 Gold Knight ........................................................ 16 H Hyprosin ............................................................ 21 I Insulin pen needles....................................... 16, 22 Insulin syringes disposable with attached needle ............................................... 16 Insulin syringes, disposable with attached needle ............................................... 22 L Leflunomide ................................................. 18, 22 N Naproxen sodium ............................................... 20 Nitroderm TTS.............................................. 18, 22 Norvir .............................................. 16, 20, 21, 22 O Oestradiol .......................................................... 18 Omeprazole.................................................. 18, 22 P Parvolex ............................................................. 20 Povidone iodine ................................................. 18 Prazosin hydrochloride ....................................... 21 Pyrazinamide ..................................................... 17 R Ritonavir .......................................... 16, 20, 21, 22 S Sulphacetamide sodium ..................................... 20 Sunscreens, proprietary ..................................... 18 Synflex............................................................... 20 V Venlafaxine .................................................. 16, 23 Verapamil .......................................................... 23 Verapamil hydrochloride ..................................... 21 Verpamil ...................................................... 21, 23 W Water ................................................................. 20 X Xanax................................................................. 20

Pharmaceutical Management Agency Level 14, Cigna House, 40 Mercer Street, PO Box 10-254, Wellington 6143, New Zealand Phone: 64 4 460 4990 - Fax: 64 4 460 4995 - www.pharmac.govt.nz Freephone Information line (9am-5pm weekdays) 0800 66 00 50

While care has been taken in compiling this Update, Pharmaceutical Management Agency takes no responsibility for any errors or omissions and shall not be liable to any person for any damages or loss arising out of reliance by that person for any purpose on any of the contents of this Update. Errors and omissions brought to the attention of Pharmaceutical Management Agency will be corrected if necessary by an erratum or otherwise in the next edition of the Update.

Metadata

Title

Schedule Update - effective 1 May 2008

Abstract

Page 1

Note

This text has been extracted from the source PDF document.

Also available as plain text.

Please contact webmaster to discuss alternative format options.